Transmission Dynamics of the Four Dengue Serotypes in Southern Vietnam and the Potential Impact of Vaccination

Abstract

BackgroundWith approximately 2.5 billion people at risk, dengue is a major international public health concern. Dengue vaccines currently in development should help reduce the burden associated with this disease but the most efficient way of using future dengue vaccines remains to be defined. Mathematical models of transmission can provide insight into the expected impact of different vaccination strategies at a population level and contribute to this definition.Methods and FindingsWe developed and analyzed an age-structured, host-vector and serotype-specific compartmental model, including seasonality. We first used this transmission model to identify the immunological interactions between serotypes that affect the risks and consequences of secondary infections (cross-protection, increased susceptibility, increased severity, and increased infectiousness) and reproduce the observed epidemiology of dengue. For populating this model, we used routine surveillance data from Southern Vietnam and the results of a prospective cohort study conducted in the same area. The model provided a good fit to the observed data for age, severity of cases, serotype distribution, and dynamics over time, using two scenarios of immunological interaction : short term cross-protection alone (6–17 months) or a combination of short term cross-protection with cross-enhancement (increased susceptibility, severity and infectiousness in the case of secondary infections). Finally, we explored the potential impact of vaccination for these two scenarios. Both highlighted that vaccination can substantially decrease dengue burden by reducing the magnitude and frequency of outbreaks.ConclusionOur model suggests that seasonality and short term cross-protection are key factors for explaining dengue dynamics in Southern Vietnam. Vaccination was predicted to significantly reduce the disease burden, even in the situation where immunological cross-enhancement affects the risks and consequences of secondary infections.

Seroprevalence of Neutralizing Antibodies Against Dengue Virus in Two Localities in the State of Morelos, Mexico

“…19 There are many studies in southeast Asia (SEA) that provide the necessary information to set up a vaccination program. [20][21][22] However, there are substantial differences in dengue transmission patterns between SEA and the Americas that can influence the vaccination program. [23][24][25] Consequently, the objective of this study was to determine the seroprevalence of DENV per serotype in two endemic localities in the state of Morelos.…”

Cost-effectiveness of dengue vaccination in Brazil

“…The analysis was based on a mathematical model of dengue transmission dynamics previously published by Coudeville & Garnett (Coudeville & Garnett, 2012). The model allows the assessment of disease dynamics at a population level and the impact of different dengue vaccination strategies on dengue transmission (both direct to vaccine targets and indirect for the entire population), thereby enabling the public health and economic benefits to be determined accurately.…”

Pharmacoeconomic Evaluation for Dengue Vaccine Pricing for Malaysia: Towards Affordability, Cost Effectiveness and Sustainability

“…Equation (1) describes the transmission of the virus from infective vector Iv to susceptible human Sh to give rise to the infected human Ih, with a transmission biting rate of β. Equation (1) is part of a system of eight ordinary differential equations formulated in the traditional SIR model [14,15] as illustrated in Equation (2). The entire human target population would be quickly infected if a transmission biting rate of β = 1.5 per day per mosquito were to be used [16].…”